Shravan Leonard-Murali1, Tommy Ivanics2, David S Kwon3, Xiaoxia Han4, Christopher P Steffes5, Rupen Shah6. 1. Department of Surgery, Henry Ford Hospital, 2799 West Grand Blvd, Detroit, MI, 48202, USA. Electronic address: smurali1@hfhs.org. 2. Department of Surgery, Henry Ford Hospital, 2799 West Grand Blvd, Detroit, MI, 48202, USA. Electronic address: tivanic1@hfhs.org. 3. Division of Surgical Oncology, Department of Surgery, Henry Ford Hospital, 2800 West Grand Blvd, Detroit, MI, 48202, USA. Electronic address: dkwon1@hfhs.org. 4. Department of Public Health Sciences, Henry Ford Health System, One Ford Place, Detroit, MI, 48202, USA. Electronic address: xhan2@hfhs.org. 5. Division of Surgical Oncology, Department of Surgery, Henry Ford Hospital, 2800 West Grand Blvd, Detroit, MI, 48202, USA. Electronic address: csteffe1@hfhs.org. 6. Division of Surgical Oncology, Department of Surgery, Henry Ford Hospital, 2800 West Grand Blvd, Detroit, MI, 48202, USA. Electronic address: rshah2@hfhs.org.
Abstract
INTRODUCTION: Parathyroid carcinoma (PC) is rare and often diagnosed incidentally after local resection (LR) for other indications. Although recommended treatment has traditionally been radical surgery (RS), more recent guidelines suggest that LR alone may be adequate. We sought to further investigate outcomes of RS versus LR for localized PC. MATERIALS AND METHODS: PC patients from 2004 to 2015 with localized disease were identified from the National Cancer Database, then stratified by surgical therapy: LR or RS. Demographic and clinicopathologic data were compared. Cox proportional hazard models were constructed to estimate associations of variables with overall survival (OS). OS was estimated from time of diagnosis using Kaplan-Meier curves. RESULTS: A total of 555 patients were included (LR = 522, RS = 33). The groups were comparable aside from LR patients having higher rates of unknown nodal status (66.9% versus 39.4%; p = 0.003). By multivariable analysis, RS did not have a significant association with OS (hazard ratio (HR) = 0.43, 95% confidence interval (95%CI) = 0.10, 1.83; p = 0.255), nor did positive nodal status (HR = 0.66, 95%CI = 0.09, 5.03; p = 0.692) and unknown nodal status (HR = 1.30, 95%CI = 0.78, 2.17; p = 0.311). There was no difference in OS between the LR and RS groups, with median survival not reached by either group at 10 years (median follow-up = 60.4 months; p = 0.20). CONCLUSIONS: There was no difference in OS between LR and RS for localized PC. RS and nodal status may not impact survival as previously identified, and LR should remain a valid initial surgical approach. Future higher-powered studies are necessary to assess the effects of surgical approaches on morbidity and oncologic outcomes.
INTRODUCTION: Parathyroid carcinoma (PC) is rare and often diagnosed incidentally after local resection (LR) for other indications. Although recommended treatment has traditionally been radical surgery (RS), more recent guidelines suggest that LR alone may be adequate. We sought to further investigate outcomes of RS versus LR for localized PC. MATERIALS AND METHODS: PC patients from 2004 to 2015 with localized disease were identified from the National Cancer Database, then stratified by surgical therapy: LR or RS. Demographic and clinicopathologic data were compared. Cox proportional hazard models were constructed to estimate associations of variables with overall survival (OS). OS was estimated from time of diagnosis using Kaplan-Meier curves. RESULTS: A total of 555 patients were included (LR = 522, RS = 33). The groups were comparable aside from LR patients having higher rates of unknown nodal status (66.9% versus 39.4%; p = 0.003). By multivariable analysis, RS did not have a significant association with OS (hazard ratio (HR) = 0.43, 95% confidence interval (95%CI) = 0.10, 1.83; p = 0.255), nor did positive nodal status (HR = 0.66, 95%CI = 0.09, 5.03; p = 0.692) and unknown nodal status (HR = 1.30, 95%CI = 0.78, 2.17; p = 0.311). There was no difference in OS between the LR and RS groups, with median survival not reached by either group at 10 years (median follow-up = 60.4 months; p = 0.20). CONCLUSIONS: There was no difference in OS between LR and RS for localized PC. RS and nodal status may not impact survival as previously identified, and LR should remain a valid initial surgical approach. Future higher-powered studies are necessary to assess the effects of surgical approaches on morbidity and oncologic outcomes.
Authors: Christine J O'Neill; Conan Chan; James Symons; Diana L Learoyd; Stan B Sidhu; Leigh W Delbridge; Anthony Gill; Mark S Sywak Journal: World J Surg Date: 2011-01 Impact factor: 3.352
Authors: Elliot A Asare; Cord Sturgeon; David J Winchester; Lei Liu; Bryan Palis; Nancy D Perrier; Douglas B Evans; David P Winchester; Tracy S Wang Journal: Ann Surg Oncol Date: 2015-06-16 Impact factor: 5.344
Authors: Ioannis Christakis; Angelica M Silva; Lily Joy Kwatampora; Carla L Warneke; Callisia N Clarke; Michelle D Williams; Elizabeth G Grubbs; Jeffrey E Lee; Naifa L Busaidy; Nancy D Perrier Journal: J Surg Oncol Date: 2016-10-18 Impact factor: 3.454
Authors: Naifa L Busaidy; Camilo Jimenez; Mouhammed Amir Habra; Pamela N Schultz; Adel K El-Naggar; Gary L Clayman; Joshua A Asper; Eduardo M Diaz; Douglas B Evans; Robert F Gagel; Adam Garden; Ana O Hoff; Jeffrey E Lee; William H Morrison; David I Rosenthal; Steven I Sherman; Erich M Sturgis; Steven G Waguespack; Randal S Weber; Kelly Wirfel; Rena Vassilopoulou-Sellin Journal: Head Neck Date: 2004-08 Impact factor: 3.147
Authors: Janneke E Witteveen; Harm R Haak; Job Kievit; Hans Morreau; Johannes A Romijn; Neveen A T Hamdy Journal: Horm Cancer Date: 2010-11-19 Impact factor: 3.869
Authors: Deborah van Dijk; Boukje A C van Dijk; Annemieke Weistra; Thera P Links; John Th M Plukker Journal: Ann Surg Oncol Date: 2020-04-23 Impact factor: 5.344
Authors: Diani Kartini; Ahmad Kurnia; Erwin Danil Yulian; Sonar Soni Panigoro; I Gusti Ngurah Gunawan Wibisana; Jessica Wardana Journal: Int J Surg Case Rep Date: 2022-07-09